New vaccine shown promise in preventing secondary strokes after an ischemic stroke

New research published in journal¬†Hypertension shows that vaccine called S100A9 may be able to replace oral blood thinners to reduce the risk of secondary strokes in patients with recent¬†ischemic stroke. Japanese researchers successfully tested an experimental vaccine in mice and found that it provided protection against blood clots for more than two months without increasing… Continue reading New vaccine shown promise in preventing secondary strokes after an ischemic stroke

Researchers create heat stable vaccines using silica

Researchers¬†at the University of Bath, working with colleagues at the University of Newcastle, have created a technique which can keep vaccines intact at high temperatures by encasing them in silica cages. When a protein in solution is mixed with silica, silicon dioxide binds closely around the protein to match its shape and encases the protein.… Continue reading Researchers create heat stable vaccines using silica

Current vaccination trials using Zika Purified Inactivated Virus (ZPIV) vaccine

The first of five early stage clinical trials to test the safety and ability of an investigational Zika vaccine candidate called the Zika Purified Inactivated Virus (ZPIV) vaccine to generate an immune system response has begun at the Walter Reed Army Institute of Research (WRAIR) Clinical Trial Center in Silver Spring, Maryland. The experimental Zika… Continue reading Current vaccination trials using Zika Purified Inactivated Virus (ZPIV) vaccine

Scientists find why it is difficult to create vaccine for Hepatitis C virus

Researchers have been trying for decades to develop a vaccine against the globally endemic hepatitis C virus (HCV). Now scientists at The Scripps Research Institute (TSRI) have discovered one reason why success has so far been elusive. Using a sophisticated array of techniques for mapping tiny molecular structures, the TSRI scientists analyzed a lab-made version… Continue reading Scientists find why it is difficult to create vaccine for Hepatitis C virus

New vaccine targets found for Plasmodium vivax Malaria

Thousands died and more than 13 million people fell ill with malaria caused by the parasite Plasmodium vivax last year. There is no vaccine for the disease, partly because multiple strains of P. vivax circulate globally, making it difficult to develop a vaccine. Now, researchers studying a protein crucial for the parasite’s survival have found… Continue reading New vaccine targets found for Plasmodium vivax Malaria